Highway Pharmaceuticals

Highway Pharmaceuticals

Early Stage

Safer, better pharmaceuticals for animal autoimmune diseases

Safer, better pharmaceuticals for animal autoimmune diseases

Overview

Raised to Date: Raised: $106,155

Total Commitments ($USD)

Platform

Wefunder

Start Date

10/20/2022

Close Date

02/23/2023

Min. Goal
$50,000
Max. Goal
$124,000
Min. Investment

$100

Security Type

SAFE

Series

Pre-Seed

SEC Filing Type

RegCF    Open SEC Filing

Valuation Cap

$5,000,000

Discount

0%

Rolling Commitments ($USD)

Status
Funded
Reporting Date

02/27/2023

Days Remaining
Funded
% of Min. Goal
Funded
% of Max. Goal
Funded
Likelihood of Max
Funded
Avg. Daily Raise

$843

# of Investors

60

Momentum
Funded
Create a free account today to gain access to KingsCrowd analytics.
Year Founded

2021

Industry

Healthcare & Pharmaceuticals

Tech Sector

HealthTech

Distribution Model

B2B

Margin

Medium

Capital Intensity

High

Location

Boston, Massachusetts

Business Type

Growth

Highway Pharmaceuticals, with a valuation of $5 million, is raising funds on Wefunder. The company makes safer and better pharmaceuticals for animal autoimmune diseases. Highway Pharmaceuticals aims to treat feline stomatitis without dental extraction by combining the immunosuppressant cyclosporine with its own metabolic inhibitor. The company is led by an experienced team and has a proven mechanism of action. Trevor Klee founded Highway Pharmaceuticals in March 2021. The current crowdfunding campaign has a minimum target of $50,000 and a maximum target of $124,000. The campaign proceeds will be used for the initial animal trial to test the safety and efficacy of the drug combination.

Summary Profit and Loss Statement

Most Recent Year Prior Year

Revenue

$0

$0

COGS

$0

$0

Tax

$0

$0

 

 

Net Income

$-23,337

$0

Summary Balance Sheet

Most Recent Year Prior Year

Cash

$0

$0

Accounts Receivable

$0

$0

Total Assets

$0

$0

Short-Term Debt

$0

$0

Long-Term Debt

$0

$0

Total Liabilities

$0

$0

Financials as of: 10/20/2022
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.

Create your first portfolio

Create your own startup investment portfolio on KingsCrowd.

Track all of your startup investments in one place using our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
Highway Pharmaceuticals on Wefunder 2022
Platform: Wefunder
Security Type: SAFE
Valuation: $5,000,000

Follow company

Follow Highway Pharmaceuticals on Wefunder 2022

Buy Highway Pharmaceuticals's Deal Report

Warning: according to the close date for this deal, Highway Pharmaceuticals may no longer be accepting investments.

Highway Pharmaceuticals Deal Report

Get KingsCrowd’s comprehensive report on Highway Pharmaceuticals including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Highway Pharmaceuticals is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Highway Pharmaceuticals deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge